New psychoactive substances, originally developed as potential analgesics but abandoned due to adverse side effects, may ...

An experimental new medication claims to help people lose weight without muscle loss. Here’s what you need to know about the ...

Yao Pharma’s deal with the US pharmaceutical giant underscores China’s growing role in global biotech licensing.

New psychoactive substances, originally developed as potential analgesics but abandoned due to adverse side effects, may ...

A preliminary study of people with diabetes suggests that use of glucose-lowering GLP-1 drugs may be linked to a lower risk ...

Giredestrant lowered the risk of disease recurrence or death by 30%, compared with standard-of-care endocrine therapy, according to the company.

We knew that GLP-1 drugs like Ozempic and Wegovy did more than just help control type 2 diabetes and aid weight loss, but the ...

The study thus suggests yet another unexpected avenue for the GLP-1 drugs.

Among more than 4,000 patients with hormone receptor (HR)-positive disease, 3-year invasive disease-free survival (IDFS) ...

Northwell Health reports that "Ozempic face" describes the facial changes from rapid weight loss using Ozempic, highlighting ...

Sacituzumab does not improve outcomes vs chemotherapy when used as the first treatment after endocrine therapy failure in HR+/HER2- advanced breast cancer, the ASCENT-07 trial finds.